These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32536370)

  • 1. NR5A2 synergizes with NCOA3 to induce breast cancer resistance to BET inhibitor by upregulating NRF2 to attenuate ferroptosis.
    Qiao J; Chen Y; Mi Y; Jin H; Huang T; Liu L; Gong L; Wang L; Wang Q; Zou Z
    Biochem Biophys Res Commun; 2020 Sep; 530(2):402-409. PubMed ID: 32536370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATF2 inhibits ani-tumor effects of BET inhibitor in a negative feedback manner by attenuating ferroptosis.
    Wang L; Chen Y; Mi Y; Qiao J; Jin H; Li J; Lu Z; Wang Q; Zou Z
    Biochem Biophys Res Commun; 2021 Jun; 558():216-223. PubMed ID: 33008584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophages confer resistance to BET inhibition in triple-negative breast cancer by upregulating IKBKE.
    Qiao J; Chen Y; Mi Y; Jin H; Wang L; Huang T; Li H; Song Y; Cao J; Wu B; Wang Q; Zou Z
    Biochem Pharmacol; 2020 Oct; 180():114126. PubMed ID: 32603665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of microRNA-17 and microRNA-20b promotes breast cancer resistance to taxol therapy by upregulation of NCOA3.
    Ao X; Nie P; Wu B; Xu W; Zhang T; Wang S; Chang H; Zou Z
    Cell Death Dis; 2016 Nov; 7(11):e2463. PubMed ID: 27831559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
    Roh JL; Kim EH; Jang H; Shin D
    Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
    Shin D; Kim EH; Lee J; Roh JL
    Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of GSK3β/Nrf2 signaling pathway modulated erastin-induced ferroptosis in breast cancer.
    Wu X; Liu C; Li Z; Gai C; Ding D; Chen W; Hao F; Li W
    Mol Cell Biochem; 2020 Oct; 473(1-2):217-228. PubMed ID: 32642794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LRH1 enhances cell resistance to chemotherapy by transcriptionally activating MDC1 expression and attenuating DNA damage in human breast cancer.
    Wang S; Zou Z; Luo X; Mi Y; Chang H; Xing D
    Oncogene; 2018 Jun; 37(24):3243-3259. PubMed ID: 29545602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-inhibition of BET proteins and NF-κB as a potential therapy for colorectal cancer through synergistic inhibiting MYC and FOXM1 expressions.
    Wu T; Wang G; Chen W; Zhu Z; Liu Y; Huang Z; Huang Y; Du P; Yang Y; Liu CY; Cui L
    Cell Death Dis; 2018 Feb; 9(3):315. PubMed ID: 29472532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment.
    Hsieh CH; Hsieh HC; Shih FS; Wang PW; Yang LX; Shieh DB; Wang YC
    Theranostics; 2021; 11(14):7072-7091. PubMed ID: 34093872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NCoA3 upregulation in breast cancer‑associated adipocytes elicits an inflammatory profile.
    Lira MC; Rosa FD; Aiello I; Machado MS; Palma AG; Paz L; Güemes MCS; Burlando S; Azurmendi PJ; Paladino N; Costas MA; Rubio MF
    Oncol Rep; 2023 May; 49(5):. PubMed ID: 37026525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ibuprofen induces ferroptosis of glioblastoma cells via downregulation of nuclear factor erythroid 2-related factor 2 signaling pathway.
    Gao X; Guo N; Xu H; Pan T; Lei H; Yan A; Mi Y; Xu L
    Anticancer Drugs; 2020 Jan; 31(1):27-34. PubMed ID: 31490283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific Activation
    Li G; Zhang Z; Reszka-Blanco N; Li F; Chi L; Ma J; Jeffrey J; Cheng L; Su L
    J Virol; 2019 Jun; 93(12):. PubMed ID: 30971469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin.
    Liu Q; Wang K
    Cell Biol Int; 2019 Nov; 43(11):1245-1256. PubMed ID: 30811078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression.
    Zhu J; Zou Z; Nie P; Kou X; Wu B; Wang S; Song Z; He J
    Cell Death Dis; 2016 Nov; 7(11):e2454. PubMed ID: 27809310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin C supplementation expands the therapeutic window of BETi for triple negative breast cancer.
    Mustafi S; Camarena V; Qureshi R; Yoon H; Volmar CH; Huff TC; Sant DW; Zheng L; Brothers SP; Wahlestedt C; Slingerland J; Wang G
    EBioMedicine; 2019 May; 43():201-210. PubMed ID: 30975544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2
    Nagpal A; Redvers RP; Ling X; Ayton S; Fuentes M; Tavancheh E; Diala I; Lalani A; Loi S; David S; Anderson RL; Smith Y; Merino D; Denoyer D; Pouliot N
    Breast Cancer Res; 2019 Aug; 21(1):94. PubMed ID: 31409375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAD2L2 inhibits colorectal cancer growth by promoting NCOA3 ubiquitination and degradation.
    Li Y; Li L; Chen M; Yu X; Gu Z; Qiu H; Qin G; Long Q; Fu X; Liu T; Li W; Huang W; Shi D; Kang T; Luo M; Wu X; Deng W
    Mol Oncol; 2018 Mar; 12(3):391-405. PubMed ID: 29360267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging mechanisms and applications of ferroptosis in the treatment of resistant cancers.
    Li B; Yang L; Peng X; Fan Q; Wei S; Yang S; Li X; Jin H; Wu B; Huang M; Tang S; Liu J; Li H
    Biomed Pharmacother; 2020 Oct; 130():110710. PubMed ID: 33568263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The discovery and characterization of K-563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp.
    Hori R; Yamaguchi K; Sato H; Watanabe M; Tsutsumi K; Iwamoto S; Abe M; Onodera H; Nakamura S; Nakai R
    Cancer Med; 2019 Mar; 8(3):1157-1168. PubMed ID: 30735010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.